Brinzolamide

Recognised as one of the most reliable Bimatoprost API Manufacturers in India, we operate from our state-of-the-art manufacturing facility located in Vadodara, Gujarat. Our team of experienced scientists and regulatory experts ensures that the production of Bimatoprost API is compliant with global pharmacopoeial requirements, including USFDA and EU guidelines. As one of the most trusted Bimatoprost API Manufacturers in Vadodara, Gujarat, we are dedicated to maintaining product integrity through rigorous quality assurance and control processes.

Century Pharma Ltd. also offers flexible and reliable supply solutions as a Bimatoprost API Trader in India. With a wide distribution network and strong logistics support, we cater to the varied procurement needs of pharmaceutical companies across the country. Whether you are seeking a reliable Bimatoprost API Trader in Gujarat or a dependable partner in Vadodara, our team ensures timely delivery and competitive pricing to keep your production timelines on track.

Driven by innovation and customer-centricity, Century Pharma, an excellent Bimatoprost API Trader in Vadodara, goes beyond API supply by offering long-term partnerships for the development of new APIs and the manufacturing of key intermediates. As one of the leading Bimatoprost API Manufacturers in Gujarat, we are committed to delivering excellence through precision, compliance, and trust, helping our global clients achieve sustainable growth and product innovation in the ophthalmic care segment.


Global Presence

Century Pharma has established a robust global presence, delivering high-quality Active Pharmaceutical Ingredients (APIs) and services across key international markets. With strong footprints in Egypt, Vietnam, Mexico, Russia, Korea, and several MENA/GCC countries (Algeria, Bahrain, Djibouti, Egypt, Iran, Iraq, Jordan, Kuwait, Lebanon, Libya, Mauritania, Morocco, Oman, Qatar, Saudi Arabia, Somalia, Sudan, Syria, Tunisia, the United Arab Emirates, and Yemen.), Century Pharma supports pharmaceutical advancements worldwide. Our expertise spans API manufacturing for human and animal health, enzyme production, biotechnology, and API research.

Additionally, Century Pharma excels in Contract API Manufacturing, Contract API Research, Method API Development, and Stability Studies, catering to regulatory and market-specific needs. As a trusted API manufacturer in India, Century Pharma continues to expand its global reach, fostering long-term collaborations and ensuring quality healthcare solutions across continents.

Contact today for support & solutions.








    Frequently Asked Questions

    Century Pharma Ltd. is a Brinzolamide API manufacturer based in Vadodara, Gujarat, India. We support pharmaceutical companies with API sourcing and commercial enquiries. Contact our team to discuss your required quantity, product specifications, and delivery needs.

    Pharmaceutical buyers can enquire about the applicable Certificate of Analysis (COA) and product specifications. These documents help buyers evaluate API identity, purity, and batch quality. Contact Century Pharma to confirm documentation availability for your requirements.

    The minimum order quantity depends on product availability, required grade, and commercial requirements. Buyers can share their expected purchase quantity with Century Pharma to confirm MOQ, pricing, and delivery schedules.

    Century Pharma serves international pharmaceutical markets. Buyers can enquire about Brinzolamide API availability, export documentation, and delivery arrangements for their destination country. Supply is subject to applicable regulatory requirements.

    To request a quotation, share your required quantity, product grade, quality specifications, destination country, and expected delivery schedule. Century Pharma can review your requirements and provide available commercial information.

    Buyers should review assay, identification, related substances, residual solvents, and applicable pharmacopoeial specifications. They should also check stereochemical purity, particle size, and batch consistency. These parameters help pharmaceutical manufacturers evaluate API quality and formulation suitability.

    Manufacturers should evaluate API purity, particle size distribution, solid-state properties, stability, and formulation compatibility. Particle size is especially important for ophthalmic suspensions. Buyers should also review relevant microbial and endotoxin requirements before supplier approval.

    Century Pharma has been identified as a source of Brinzolamide USP Micronized API in published pharmaceutical regulatory records. However, buyers should confirm current grade availability, particle size specifications, and supporting quality documentation before ordering.

    Brinzolamide is poorly soluble in water and is commonly formulated as an ophthalmic suspension. Particle size distribution can influence suspension performance, sedimentation, redispersion, and formulation quality. Buyers should review the required particle size specifications and analytical test methods.

    Brinzolamide and Dorzolamide Hydrochloride are different carbonic anhydrase inhibitor APIs. Both are used in approved ophthalmic medicines to reduce elevated intraocular pressure. However, they differ in chemical structure, solubility, and formulation characteristics. Pharmaceutical manufacturers should select the correct API based on their approved product specifications.

    WhatsApp
    Download Brochure